Daniel Krauser is a Cardiology physician affiliated with Hospital for Special Surgery. OpenAlex indexes 27 publications with 2,940 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
133 E 58th St Ste 301
New York, NY 100221168
Telephone
212-755-8700Provider last certified this registry record 28 Apr 2021.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20252 payments
- Baxter HealthcareProgram year20251 payment
- Lilly USA, LLCProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
70.1%Statin18.2%Rosuvastatin Calcium44%Atorvastatin Calcium43%Pravastatin Sodium6%Simvastatin4%Livalo2%Part D<11 patientsBeta blocker10.9%Metoprolol Succinate59%Carvedilol12%Metoprolol Tartrate8%Bisoprolol Fumarate8%Atenolol7%Nebivolol Hcl4%Propranolol Hcl Er3%Part D<11 patients+ 18 more classes in this area
Metabolism & gastrointestinal
12.1%GLP-1 receptor agonist3.5%Mounjaro49%Ozempic41%Wegovy11%Part D<11 patientsBiguanide (metformin)3.2%Metformin Hcl54%Metformin Hcl Er46%Part D≥39 patients+ 6 more classes in this area
Blood & clotting
8.9%Factor Xa inhibitor7.6%Eliquis88%Xarelto12%Part D≥113 patientsVitamin K antagonist0.7%Warfarin Sodium100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Hemodynamic effects of angiotensin inhibitors in elderly hypertensives undergoing total knee arthroplasty under regional anesthesia
Journal of the American Society of Hypertension
2014 - First Time Myocardial Infarction in a Rheumatic Patient after Elective Arthroplasty
HSS Journal® The Musculoskeletal Journal of Hospital for Special Surgery
2013 - Cardiac Arrest during Total Hip Arthroplasty in a Patient on an Angiotensin Receptor Antagonist
HSS Journal® The Musculoskeletal Journal of Hospital for Special Surgery
2012 - Prognostic Value of Multiple Biomarkers in American Indians Free of Clinically Overt Cardiovascular Disease (from the Strong Heart Study)
The American Journal of Cardiology
2009
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Lockshin, MD
Hospital for Special Surgery
Lionel Ivashkiv, MD
Hospital for Special Surgery
Vivian Bykerk, VIVIAN, BYKERK, MD
Hospital for Special Surgery
Jane Salmon, MD
Hospital for Special Surgery
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”